Literature DB >> 9361091

Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma.

N Ando1, A Nakao, S Nomoto, S Takeda, T Kaneko, T Kurokawa, T Nonami, H Takagi.   

Abstract

In this study, we attempted to detect K-ras point mutations by means of two-stage polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) to diagnose micrometastases in paraaortic lymph nodes of patients with pancreatic adenocarcinoma. Main carcinoma tissues and corresponding lymph nodes in the paraaortic region were obtained from 15 patients who underwent extended radical surgery including the wide dissection of lymph nodes and who were diagnosed as lymph node negative by routine histological examination. DNA was extracted from the tissue specimens, and PCR/RFLP analysis was used to detect K-ras oncogene mutations at codon 12. Thirteen of the primary tumors were found to have K-ras mutations. In eight of the 13 cases, 42 of the 101 lymph nodes showed K-ras point mutations in the paraaortic lymph nodes. These results suggested that PCR/RFLP analysis is potentially highly sensitive for the detection of micrometastases in lymph nodes and that it may be useful in reaching an accurate assessment of the lymphatic dissemination of pancreatic adenocarcinoma at the molecular level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361091     DOI: 10.1097/00006676-199711000-00007

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  9 in total

Review 1.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Impact of lymph node micrometastasis in patients with pancreatic head cancer.

Authors:  Hiroshi Kurahara; Sonshin Takao; Kousei Maemura; Hiroyuki Shinchi; Shoji Natsugoe; Takashi Aikou
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

3.  Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival.

Authors:  Edlyn Soeth; Urte Grigoleit; Barbara Moellmann; Christian Röder; Bodo Schniewind; Bernd Kremer; Holger Kalthoff; Ilka Vogel
Journal:  J Cancer Res Clin Oncol       Date:  2005-09-01       Impact factor: 4.553

4.  [Significance of occult lymphatic tumor spread in pancreatic cancer].

Authors:  C Milsmann; L Füzesi; C Werner; H Becker; O Horstmann
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

Review 5.  Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination.

Authors:  D Bogoevski; T Strate; E F Yekebas; J R Izbicki
Journal:  Langenbecks Arch Surg       Date:  2008-01-17       Impact factor: 3.445

6.  Pancreatic cancer--low survival rates.

Authors:  Hans G Beger; Bettina Rau; Frank Gansauge; Gerd Leder; Michael Schwarz; Bertram Poch
Journal:  Dtsch Arztebl Int       Date:  2008-04-04       Impact factor: 5.594

7.  Treatment of pancreatic cancer: challenge of the facts.

Authors:  Hans G Beger; Bettina Rau; Frank Gansauge; Bertram Poch; Karl-Heinz Link
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

8.  Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO).

Authors:  Thomas B Brunner; Gerhard G Grabenbauer; Thomas Meyer; Henriette Golcher; Rolf Sauer; Werner Hohenberger
Journal:  BMC Cancer       Date:  2007-03-06       Impact factor: 4.430

Review 9.  Molecular mechanism underlying lymphatic metastasis in pancreatic cancer.

Authors:  Zhiwen Xiao; Guopei Luo; Chen Liu; Chuntao Wu; Liang Liu; Zuqiang Liu; Quanxing Ni; Jiang Long; Xianjun Yu
Journal:  Biomed Res Int       Date:  2014-01-22       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.